Compare PMI & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMI | PROF |
|---|---|---|
| Founded | 1981 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.7M | 230.4M |
| IPO Year | 2025 | N/A |
| Metric | PMI | PROF |
|---|---|---|
| Price | $1.80 | $7.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 184.6K | ★ 240.4K |
| Earning Date | 03-20-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,767,000.00 | ★ $14,297,000.00 |
| Revenue This Year | N/A | $64.23 |
| Revenue Next Year | N/A | $113.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 8.81 | ★ 67.94 |
| 52 Week Low | $1.58 | $3.76 |
| 52 Week High | $13.68 | $8.95 |
| Indicator | PMI | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 43.83 |
| Support Level | $1.74 | $7.40 |
| Resistance Level | $1.89 | $8.15 |
| Average True Range (ATR) | 0.13 | 0.55 |
| MACD | 0.06 | -0.12 |
| Stochastic Oscillator | 50.00 | 5.09 |
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.